Quin2 Microfluorometry and Effects of Verapamil and Diltiazem on Calcium Release from Rat Aorta Smooth Muscle Cells in Primary Culture
Overview
Affiliations
We investigated the effects of the Ca2+ antagonists diltiazem and verapamil on release of Ca2+ from intracellular store sites of rat aorta vascular smooth muscle cells in primary culture. Using the microfluorometry of Ca2+-indicator dye quin2, relative changes in cytosolic Ca2+ concentration could be measured. In the presence of 1 mM extracellular Ca2+, both diltiazem (IC50, 0.31 microM) and verapamil (IC50, 0.47 microM) dose-dependently inhibited elevations in the cytosolic Ca2+, as induced by depolarization of the plasma membrane with high extracellular K+. In the absence of extracellular Ca2+, caffeine and high extracellular K+ induced transient and dose-dependent elevations of the cytosolic Ca2+, and these elevations were not inhibited by either diltiazem or verapamil. Norepinephrine also induced a transient and dose-dependent elevation of cytosolic Ca2+ in the absence of extracellular Ca2+. However, this elevation was inhibited by verapamil and diltiazem (when the norepinephrine concentration was 10(-5) M, IC50 for verapamil and diltiazem was 4.0 and 24.9 microM, respectively). Thus, while verapamil and diltiazem may have no direct effect on the release of Ca2+ from the depolarization- and the caffeine-sensitive intracellular Ca2+ storage sites, the agents do seem to inhibit the adrenoceptor-mediated Ca2+ release mechanism in vascular smooth muscle cells.
Karashima E, Nishimura J, Iwamoto T, Hirano K, Hirano M, Kita S Br J Pharmacol. 2007; 150(4):434-44.
PMID: 17220909 PMC: 2189722. DOI: 10.1038/sj.bjp.0707119.
Zhu F, Huang B, Hu C, Jiang Q, Lu Z, Lu M Chin J Integr Med. 2006; 11(4):287-92.
PMID: 16417780 DOI: 10.1007/BF02835791.
Ng L, Wilson S, Hume J J Physiol. 2004; 563(Pt 2):409-19.
PMID: 15613369 PMC: 1665594. DOI: 10.1113/jphysiol.2004.078311.
Robertson T, Hague D, Aaronson P, Ward J J Physiol. 2000; 525 Pt 3:669-80.
PMID: 10856120 PMC: 2269969. DOI: 10.1111/j.1469-7793.2000.t01-1-00669.x.
Noguera M, Calatayud S, DOcon M Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(5):472-7.
PMID: 7906867 DOI: 10.1007/BF00173205.